Report Code : CVMI25074 | Published Date : July 27, 2025

Market Overview

Syphilis testing is crucial for early detection, treatment tracking, and prevention of Treponema pallidum infections. The market includes various diagnostics such as rapid point-of-care tests (POCT), automated immunoassays, and confirmatory treponemal and non-treponemal tests (e.g., RPR, VDRL, FTA-ABS). The increased prevalence of syphilis, particularly in high-risk groups, along with public health efforts focusing on maternal screening and STI control initiatives, is boosting demand.

The market is also driven by higher adoption of dual HIV/syphilis rapid tests, decentralization of STI testing, and integration of diagnostic services into primary and reproductive healthcare. Key technologies include lateral flow assays, chemiluminescence immunoassays (CLIA), and molecular PCR-based methods for confirmatory diagnostics.

Market Size and Forecast

Year

Market Value (USD Billion)

Notes

2019

0.86

Baseline from WHO and national STI testing volumes

2024

1.37

Global POCT uptake and integrated STI testing programs

2031

2.21

Seven-year CAGR 7.1% (2024–2031)

Increasing antenatal and community-based screening could push the market beyond USD 2.3 billion by 2031.

Primary Market Drivers

• Rising global incidence of syphilis, especially congenital and recurrent cases
• National screening requirements in antenatal care and STI clinics
• WHO and UNAIDS-led deployment of dual HIV/syphilis rapid tests
• Expansion of decentralized diagnostics through point-of-care testing (POCT) in resource-limited settings
• Technology convergence facilitating multiplex STI detection kits

Market Challenges

• Underreporting and stigma reduce screening demand in some regions
• Limited access to confirmatory testing in rural and low-resource settings
• Reagent shortages and supply disruptions affect public health labs
• Variability in sensitivity and specificity of point-of-care diagnostics

Competitive Landscape

Company / Organization

2024 Share

Core Strengths

Recent Moves

Abbott Laboratories

20 %

Architect CLIA platforms, Determine rapid tests

Rolled out dual HIV/syphilis POCT in 15 countries (Q4 2024)

Bio-Rad Laboratories

17 %

RPR, VDRL, and TPHA diagnostic kits

Launched automated screening solution for public labs (Q2 2025)

SD Biosensor

13 %

Affordable lateral flow tests for LMICs

Partnered with African STI programs for mobile labs (Q1 2025)

Thermo Fisher Scientific

10 %

Molecular confirmatory kits and analyzers

Acquired small treponemal assay firm (Q3 2024)

Others (Trinity Biotech, Chembio, Biopanda, NG Biotech)

40 %

Niche rapid test formats and regional manufacturing

  

Detailed Market Segmentation

By Test Type
• Treponemal Tests (FTA-ABS, TPHA, EIA) – 43 %
• Non-Treponemal Tests (RPR, VDRL) – XX %
• Rapid Point-of-Care Tests – XX %
• Molecular Diagnostic Tests – XX %

By Sample Type
• Blood – 64 %
• Serum – XX %
• Oral Fluid – XX %
• Others (Cerebrospinal Fluid, Genital Swabs) – XX %

By End User
• Hospitals – 34 %
• Diagnostic Laboratories – XX %
• Community Clinics & Mobile Health Units – XX %
• NGOs & Public Health Programs – XX %

Regional Analysis

• North America (30%) – Strong integration into STI clinics and antenatal care; CDC and state mandates support screening
• Europe (XX%) – Universal prenatal screening and digital lab automation in urban hospitals
• Asia-Pacific (XX%) – High disease burden in Southeast Asia; WHO-backed test adoption in India and Philippines
• Latin America & MEA (XX%) – Regional WHO/PAHO programs boosting decentralized POCT deployment

Technology and Innovation

• Dual HIV/syphilis rapid tests for integrated disease surveillance
• Multiplex PCR panels detecting syphilis alongside chlamydia, gonorrhea, and HIV
• AI-driven diagnostic analytics in laboratory-based screening programs
• Compact, solar-powered POCT analyzers for rural clinics
• Digital connectivity for result reporting and follow-up reminders

Regulatory Environment

• WHO Prequalification programs for global test procurement
• FDA and CE clearances for lab-based and POCT platforms
• Global Fund and USAID guidelines on STI test sensitivity/specificity
• National EML inclusion and procurement frameworks in LMICs

Recent Developments (Q4 2023 – Q2 2025)

• Abbott expanded Determine POCT in Asia and Africa (Q4 2024) 
• SD Biosensor introduced handheld test readers for mobile clinics (Q1 2025) 
• Bio-Rad launched automated RPR/TPHA analyzers in public labs (Q2 2025) 
• Thermo Fisher acquired a treponemal PCR firm to enhance confirmatory offerings (Q3 2024) 
• UNAIDS piloted self-testing kits for at-risk populations in Latin America (Q1 2025)

Strategic Outlook

• Global health initiatives should expand dual testing and incorporate digital result tracking. • Manufacturers must improve rural distribution and training for POCT devices. • NGOs and public sector buyers need affordable, high-sensitivity rapid kits with stable prices. • The expansion of molecular diagnostics will improve confirmatory testing in urban and peri-urban laboratories.

Methodology

Clearview Market Insights collected procurement data from WHO, analyzed 42 country STI program reports, and interviewed 60 healthcare providers and lab professionals. Forecasts account for global STI control goals, diagnostic tech adoption, and health system capacity changes.

About Clearview Market Insights

Clearview Market Insights provides STI and infectious disease diagnostics intelligence to aid decision-makers in healthcare, aid agencies, and global suppliers.





Reasons To Buy

• Understand syphilis testing growth dynamics across care settings
• Compare product formats and field-readiness of global test suppliers
• Track public health integration and donor funding outlook
• Evaluate regional expansion strategies for POCT and confirmatory platforms





Scope

• Revenue and volume data (2019–2031) for lab-based and point-of-care syphilis tests
• Segmentation by test type, end user, sample, and region
• Market share of leading diagnostic companies and POCT providers
• Technology trends in multiplex testing, AI analytics, and field kits
• Procurement and regulatory pathways across WHO, FDA, and LMIC programs

Abbott Laboratories

SD Biosensor

Trinity Biotech

Chembio

Biopanda

NG Biotech

DiaSorin S.p.A.

Hologic Inc.

Bio-Rad Laboratories Inc.

Thermo Fisher Scientific Inc.

Becton Dickinson and Company

Danaher Corporation

F. Hoffmann-La Roche Ltd.

Siemens Healthineers AG

Global Syphilis Testing Market Report


  1. 1. Global Syphilis Testing Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Syphilis Testing Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Global Syphilis Testing Market Research Report - Preface
    1. 2.1 Global Syphilis Testing Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Test Type
      2. 2.1.2 By Sample Type
      3. 2.1.3 By End User
      4. 2.1.4 By Region
  3. 3. Global Syphilis Testing Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Test Type, By Sample Type, By End User, By Country
    3. 3.3. Opportunities – By Test Type, By Sample Type, By End User, By Country
    4. 3.4. Trends – By Test Type, By Sample Type, By End User, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Syphilis Testing Market Research Report – DROTs Impact Analysis
    1. 4. Global Syphilis Testing Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    2. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    4. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    5. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 5. Global Syphilis Testing Market, By Test Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Treponemal Tests (FTA-ABS, TPHA, EIA)
    2. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 5.2 Non-Treponemal Tests (RPR, VDRL)
    7. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 5.3 Rapid Point-of-Care Tests
    12. 5.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 5.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 5.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 5.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 5.4 Molecular Diagnostic Tests
    17. 5.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 5.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 5.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 5.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Syphilis Testing Market, By Sample Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Blood
    2. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 6.2 Serum
    7. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 6.3 Oral Fluid
    12. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 6.4 Others (Cerebrospinal Fluid, Genital Swabs)
    17. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Syphilis Testing Market, By End User, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Hospitals
    2. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    3. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    4. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    5. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 7.2 Diagnostic Laboratories
    7. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    8. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    9. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    10. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    11. 7.3 Community Clinics & Mobile Health Units
    12. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    13. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    14. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    15. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    16. 7.4 NGOs & Public Health Programs
    17. 7.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    18. 7.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    19. 7.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    20. 7.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
  1. 8. Global Syphilis Testing Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.5 Middle East and Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.6 Global Syphilis Testing Market - Opportunity Analysis Index, By Test Type, By Sample Type, By End User, and Region, 2024 - 2031
  1. 9. North America Global Syphilis Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Treponemal Tests (FTA-ABS, TPHA, EIA)
      2. 9.1.2 Non-Treponemal Tests (RPR, VDRL)
      3. 9.1.3 Rapid Point-of-Care Tests
      4. 9.1.4 Molecular Diagnostic Tests
      9.2 By Sample Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Blood
      2. 9.2.2 Serum
      3. 9.2.3 Oral Fluid
      4. 9.2.4 Others (Cerebrospinal Fluid, Genital Swabs)
      9.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Hospitals
      2. 9.3.2 Diagnostic Laboratories
      3. 9.3.3 Community Clinics & Mobile Health Units
      4. 9.3.4 NGOs & Public Health Programs
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 U.S
      2. 9.4.2 Canada
    2. 9.5 North America Global Syphilis Testing Market – Opportunity Analysis Index, By Test Type, By Sample Type, By End User, and Country, 2024 - 2031
    3. 9.6 Regional Trends Analysis
    4. 9.7 North America Global Syphilis Testing Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (U.S)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Global Syphilis Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Treponemal Tests (FTA-ABS, TPHA, EIA)
      2. 10.1.2 Non-Treponemal Tests (RPR, VDRL)
      3. 10.1.3 Rapid Point-of-Care Tests
      4. 10.1.4 Molecular Diagnostic Tests
      10.2 By Sample Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Blood
      2. 10.2.2 Serum
      3. 10.2.3 Oral Fluid
      4. 10.2.4 Others (Cerebrospinal Fluid, Genital Swabs)
      10.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Hospitals
      2. 10.3.2 Diagnostic Laboratories
      3. 10.3.3 Community Clinics & Mobile Health Units
      4. 10.3.4 NGOs & Public Health Programs
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 UK
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Poland and Rest of Europe
    2. 10.5 Europe Global Syphilis Testing Market – Opportunity Analysis Index, By Test Type, By Sample Type, By End User, and Country, 2024 - 2031
    3. 10.6 Regional Trends Analysis
    4. 10.7 Europe Global Syphilis Testing Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (UK)
      3. 10.7.3 Company 3 (UK)
    11. Asia-Pacific Global Syphilis Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Treponemal Tests (FTA-ABS, TPHA, EIA)
      2. 11.1.2 Non-Treponemal Tests (RPR, VDRL)
      3. 11.1.3 Rapid Point-of-Care Tests
      4. 11.1.4 Molecular Diagnostic Tests
      11.2 By Sample Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Blood
      2. 11.2.2 Serum
      3. 11.2.3 Oral Fluid
      4. 11.2.4 Others (Cerebrospinal Fluid, Genital Swabs)
      11.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Hospitals
      2. 11.3.2 Diagnostic Laboratories
      3. 11.3.3 Community Clinics & Mobile Health Units
      4. 11.3.4 NGOs & Public Health Programs
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 Japan
      2. 11.4.2 China
      3. 11.4.3 India
      4. 11.4.4 ASEAN
      5. 11.4.5 Australia & New Zealand
      6. 11.4.6 Rest of Asia-Pacific
    2. 11.5 Asia-Pacific Global Syphilis Testing Market – Opportunity Analysis Index, By Test Type, By Sample Type, By End User, and Country, 2024 - 2031
    3. 11.6 Regional Trends Analysis
    4. 11.7 Asia-Pacific Global Syphilis Testing Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (Japan)
      2. 11.7.2 Company 2 (China)
      3. 11.7.3 Company 3 (China)
    12. Latin America Global Syphilis Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Treponemal Tests (FTA-ABS, TPHA, EIA)
      2. 12.1.2 Non-Treponemal Tests (RPR, VDRL)
      3. 12.1.3 Rapid Point-of-Care Tests
      4. 12.1.4 Molecular Diagnostic Tests
      12.2 By Sample Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Blood
      2. 12.2.2 Serum
      3. 12.2.3 Oral Fluid
      4. 12.2.4 Others (Cerebrospinal Fluid, Genital Swabs)
      12.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Hospitals
      2. 12.3.2 Diagnostic Laboratories
      3. 12.3.3 Community Clinics & Mobile Health Units
      4. 12.3.4 NGOs & Public Health Programs
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Rest of Latin America
    2. 12.5 Latin America Global Syphilis Testing Market – Opportunity Analysis Index, By Test Type, By Sample Type, By End User, and Country, 2024 - 2031
    3. 12.6 Regional Trends Analysis
    4. 12.7 Latin America Global Syphilis Testing Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East and Africa Global Syphilis Testing Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Test Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Treponemal Tests (FTA-ABS, TPHA, EIA)
      2. 13.1.2 Non-Treponemal Tests (RPR, VDRL)
      3. 13.1.3 Rapid Point-of-Care Tests
      4. 13.1.4 Molecular Diagnostic Tests
      13.2 By Sample Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Blood
      2. 13.2.2 Serum
      3. 13.2.3 Oral Fluid
      4. 13.2.4 Others (Cerebrospinal Fluid, Genital Swabs)
      13.3 By End User Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Hospitals
      2. 13.3.2 Diagnostic Laboratories
      3. 13.3.3 Community Clinics & Mobile Health Units
      4. 13.3.4 NGOs & Public Health Programs
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Gulf Cooperation Council (GCC) Countries
      2. 13.4.2 Israel
      3. 13.4.3 South Africa
      4. 13.4.4 Rest of MEA
    2. 13.5 Middle East and Africa Global Syphilis Testing Market – Opportunity Analysis Index, By Test Type, By Sample Type, By End User, and Country, 2024 - 2031
    3. 13.6 Regional Trends Analysis
    4. 13.7 Middle East and Africa Global Syphilis Testing Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Gulf Cooperation Council (GCC) Countries)
      2. 13.7.2 Company 2 (Israel)
      3. 13.7.3 Company 3 (Israel)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
    2. 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Abbott Laboratories
      2. 14.2.2 SD Biosensor
      3. 14.2.3 Trinity Biotech
      4. 14.2.4 Chembio
      5. 14.2.5 Biopanda
      6. 14.2.6 NG Biotech
      7. 14.2.7 DiaSorin S.p.A.
      8. 14.2.8 Hologic Inc.
      9. 14.2.9 Bio-Rad Laboratories Inc.
      10. 14.2.10 Thermo Fisher Scientific Inc.
      11. 14.2.11 Becton Dickinson and Company
      12. 14.2.12 Danaher Corporation
      13. 14.2.13 F. Hoffmann-La Roche Ltd.
      14. 14.2.14 Siemens Healthineers AG
      15. 14.2.15
  1. 15. Data Collection Method and Research Approach
  1. 16. Principal Presumptions and Acronyms